June 2016

Genea welcomes ZEISS and Hamilton Thorne to the Global Fertility Alliance

Posted: 30/06/2016 10:40:53 AM
As a founding member of the Global Fertility Alliance, Australian fertility pioneer Genea today welcomed two new members, ZEISS and Hamilton Thorne Ltd. Established a year ago by Genea, Merck, a leading science and technology company, and Illumina Inc, a leader in developing and commercialising systems for analysis of genetic variation and function, the alliance is a collaboration to advance excellence in fertility technologies and processes within the assisted reproductive treatment (ART) laboratory.
Read more

Media Contact

Alice Ross
M: 0421 741 737
E: alice.ross@genea.com.au

About Genea

Genea is one of Australia’s leading providers for infertility, IVF and other assisted conception treatment with 31 years of experience in the field. The company has long been a fertility pioneer, with research and technologies developed in-house virtually doubling IVF success rates in the mid-nineties and continuing to improve outcomes today. In September 2017, Genea was listed in the Australian Financial Review’s Top 50 Most Innovative Companies List, ranking number 25.

News Archives

For all enquiries, call:
Email us
LinkedIn Instagram
Genea shares patient stories to help people experiencing infertility to understand that they are not alone. Hearing about other people experiencing the same challenges is a powerful way to break the isolation and stigma that often surrounds infertility. We share these stories with the intent to inform, educate and comfort and have no intention to create unreasonable expectations of beneficial treatment. Similarly, we have no intention for our community to believe the stories told are the outcomes that would be achieved for every patient.
Home Privacy Policy Disclaimer Genea Group
© Copyright 2019 Genea Limited. ABN 82 002 844 448